Eli Lilly announces $850 million investment in U.S. operations in 2017

Eli Lilly announced plans to invest $850 million in its U.S. operations in 2017, including an $85 million expansion of Trulicity device assembly operations and a $140 million insulin cartridge production facility in Indianapolis.

“Eli Lilly and Company announced plans to invest $850 million in its U.S. operations in 2017.”drugdiscoverytrends.com

• 1 source
• drugdiscoverytrends.comEli Lilly Announces $850M Investment in U.S. Capital Projects ...Drug Discovery Trends EditorMar 31, 2017

Summarized from public sources; check the original articles before acting on it.